Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
Liufu Deng, Hua Liang, Byron Burnette, et al.
Journal of Clinical Investigation (2014) Vol. 124, Iss. 2, pp. 687-695
Open Access | Times Cited: 1887

Showing 1-25 of 1887 citing articles:

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
Scott Antonia, Augusto Villegas, Davey B. Daniel, et al.
New England Journal of Medicine (2017) Vol. 377, Iss. 20, pp. 1919-1929
Open Access | Times Cited: 3826
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Scott Antonia, Augusto Villegas, Davey B. Daniel, et al.
New England Journal of Medicine (2018) Vol. 379, Iss. 24, pp. 2342-2350
Open Access | Times Cited: 2474
Immune Checkpoint Blockade in Cancer Therapy
Michael A. Postow, Margaret K. Callahan, Jedd D. Wolchok
Journal of Clinical Oncology (2015) Vol. 33, Iss. 17, pp. 1974-1982
Open Access | Times Cited: 2435
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Weiping Zou, Jedd D. Wolchok, Lieping Chen
Science Translational Medicine (2016) Vol. 8, Iss. 328
Open Access | Times Cited: 2129
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
Holly E. Barker, James Paget, Aadil Khan, et al.
Nature reviews. Cancer (2015) Vol. 15, Iss. 7, pp. 409-425
Open Access | Times Cited: 1773
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
Liufu Deng, Hua Liang, Meng Xu, et al.
Immunity (2014) Vol. 41, Iss. 5, pp. 843-852
Open Access | Times Cited: 1739
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment
Qianghu Wang, Baoli Hu, Xin Hu, et al.
Cancer Cell (2017) Vol. 32, Iss. 1, pp. 42-56.e6
Open Access | Times Cited: 1643
Neutrophils in cancer: neutral no more
Seth B. Coffelt, Max D. Wellenstein, Karin E. de Visser
Nature reviews. Cancer (2016) Vol. 16, Iss. 7, pp. 431-446
Closed Access | Times Cited: 1550
Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade
Simon J. Dovedi, Amy L. Adlard, Grazyna Lipowska‐Bhalla, et al.
Cancer Research (2014) Vol. 74, Iss. 19, pp. 5458-5468
Open Access | Times Cited: 1153
Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
Mauro Poggio, Tianyi Hu, Chien-Chun Steven Pai, et al.
Cell (2019) Vol. 177, Iss. 2, pp. 414-427.e13
Open Access | Times Cited: 1094
Using immunotherapy to boost the abscopal effect
Wilfred Ngwa, Omoruyi Credit Irabor, Jonathan D. Schoenfeld, et al.
Nature reviews. Cancer (2018) Vol. 18, Iss. 5, pp. 313-322
Open Access | Times Cited: 1000
Radiotherapy and immunotherapy: a beneficial liaison?
Ralph R. Weichselbaum, Hua Liang, Liufu Deng, et al.
Nature Reviews Clinical Oncology (2017) Vol. 14, Iss. 6, pp. 365-379
Closed Access | Times Cited: 878
Nanoparticle‐Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
Xiaopin Duan, Christina Chan, Wenbin Lin
Angewandte Chemie International Edition (2018) Vol. 58, Iss. 3, pp. 670-680
Open Access | Times Cited: 853
Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
Ming Yi, Xiaoli Zheng, Mengke Niu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 835
Coinhibitory Pathways in Immunotherapy for Cancer
Susanne H.C. Baumeister, Gordon J. Freeman, Glenn Dranoff, et al.
Annual Review of Immunology (2016) Vol. 34, Iss. 1, pp. 539-573
Closed Access | Times Cited: 832
Cancer nanomedicine for combination cancer immunotherapy
Jutaek Nam, Sejin Son, Kyong Soo Park, et al.
Nature Reviews Materials (2019) Vol. 4, Iss. 6, pp. 398-414
Closed Access | Times Cited: 812
Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11
Xueting Lang, Michael D. Green, Weimin Wang, et al.
Cancer Discovery (2019) Vol. 9, Iss. 12, pp. 1673-1685
Open Access | Times Cited: 796
Microbiota: a key orchestrator of cancer therapy
Soumen Roy, Giorgio Trinchieri
Nature reviews. Cancer (2017) Vol. 17, Iss. 5, pp. 271-285
Closed Access | Times Cited: 787
Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non–Small Cell Lung Cancer
Willemijn S.M.E. Theelen, Heike Peulen, Ferry Lalezari, et al.
JAMA Oncology (2019) Vol. 5, Iss. 9, pp. 1276-1276
Open Access | Times Cited: 782
Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy
Andrew B. Sharabi, Michael Lim, Theodore L. DeWeese, et al.
The Lancet Oncology (2015) Vol. 16, Iss. 13, pp. e498-e509
Closed Access | Times Cited: 772
Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway
Kim C. Ohaegbulam, Amer Assal, Eszter Lázár‐Molnár, et al.
Trends in Molecular Medicine (2014) Vol. 21, Iss. 1, pp. 24-33
Open Access | Times Cited: 743
PD-L1 expression in human cancers and its association with clinical outcomes
Jinming Yu, Xin Wang, Feifei Teng, et al.
OncoTargets and Therapy (2016) Vol. Volume 9, pp. 5023-5039
Open Access | Times Cited: 691
The role of myeloid cells in cancer therapies
Camilla Engblom, Christina Pfirschke, Mikaël J. Pittet
Nature reviews. Cancer (2016) Vol. 16, Iss. 7, pp. 447-462
Closed Access | Times Cited: 684
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
Jiali Yu, Michael D. Green, Shasha Li, et al.
Nature Medicine (2021) Vol. 27, Iss. 1, pp. 152-164
Open Access | Times Cited: 671
Role of Local Radiation Therapy in Cancer Immunotherapy
Sandra Demaria, Encouse B. Golden, Silvia C. Formenti
JAMA Oncology (2015) Vol. 1, Iss. 9, pp. 1325-1325
Closed Access | Times Cited: 652
Page 1 - Next Page

Scroll to top